Replies to post #8730 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

BMY gets FDA approval for Orencia manufacturing at Devens, MA plant:

http://finance.yahoo.com/news/u-fda-approves-bristol-myers-150000764.html

The Devens plant, where BMY acquired land formerly owned by a military base in 2007, cost $750M to build and has a production capacity of 150K liters. It is the newest of BMY’s two in-house biopharmaceutical plants; the other one is in Syracuse, NY.

I’ve speculated that Orencia is one of the two initial FoB’s MNTA is working on with BAX.